| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-10 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |